Literature DB >> 9674700

Involvement of Myc targets in c-myc and N-myc induced human tumors.

T Ben-Yosef1, O Yanuka, D Halle, N Benvenisty.   

Abstract

The myc proto-oncogenes are transcription factors that directly regulate the expression of other genes, by binding to the specific DNA sequence, CACGTG. Among the target genes for c-Myc regulation are ECA39, p53, ornithine decarboxylase (ODC), alpha-prothymosin and Cdc25A. In this study we examined the involvement of c-Myc target genes in human oncogenesis induced by c-myc or N-myc. In MCF-7 breast cancer cells, the induction of c-myc expression by estrogen was followed by the induction of all the Myc targets that we examined, indicating that those genes can serve as c-Myc targets in human oncogenesis. Moreover, in breast tumors exhibiting c-myc overexpression, several Myc targets were also overexpressed. A clear correlation between the expression of c-myc and its targets was also detected in Burkitt's lymphomas, which involve a specific translocation of c-myc gene, but not in other lymphoma cells. Yet, in cells derived from a neuronal origin the pattern of expression of Myc targets was more complex. In a neuroepithelioma cell line that overexpresses c-myc, only some targets were expressed. In addition in neuroblastomas, in which N-myc is amplified and overexpressed, only ODC was overexpressed in all cell lines, while all other target genes were expressed in only some of the cell lines. The more complex expression pattern found for the Myc targets in neuroblastomas suggests that genes that were identified originally as targets for c-Myc regulation may be regulated by N-Myc, but other cell specific factors are also needed for transcription of the target genes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9674700     DOI: 10.1038/sj.onc.1201939

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  29 in total

Review 1.  Polyamine synthesis as a target of MYC oncogenes.

Authors:  André S Bachmann; Dirk Geerts
Journal:  J Biol Chem       Date:  2018-11-07       Impact factor: 5.157

2.  Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system.

Authors:  Thomas P Stricker; Andres Morales La Madrid; Alexandre Chlenski; Lisa Guerrero; Helen R Salwen; Yasmin Gosiengfiao; Elizabeth J Perlman; Wayne Furman; Armita Bahrami; Jason M Shohet; Peter E Zage; M John Hicks; Hiroyuki Shimada; Rie Suganuma; Julie R Park; Sara So; Wendy B London; Peter Pytel; Kirsteen H Maclean; Susan L Cohn
Journal:  Mol Oncol       Date:  2014-01-31       Impact factor: 6.603

3.  A prolonged and exaggerated wound response with elevated ODC activity mimics early tumor development.

Authors:  Candace S Hayes; Karen Defeo; Hong Dang; Carol S Trempus; Rebecca J Morris; Susan K Gilmour
Journal:  Carcinogenesis       Date:  2011-07-05       Impact factor: 4.944

4.  Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myeloma.

Authors:  Anna Bianchi-Smiraglia; Archis Bagati; Emily E Fink; Hayley C Affronti; Brittany C Lipchick; Sudha Moparthy; Mark D Long; Spencer R Rosario; Shivana M Lightman; Kalyana Moparthy; David W Wolff; Dong Hyun Yun; Zhannan Han; Anthony Polechetti; Matthew V Roll; Ilya I Gitlin; Katerina I Leonova; Aryn M Rowsam; Eugene S Kandel; Andrei V Gudkov; P Leif Bergsagel; Kelvin P Lee; Dominic J Smiraglia; Mikhail A Nikiforov
Journal:  J Clin Invest       Date:  2018-09-10       Impact factor: 14.808

5.  p53 is a direct transcriptional target of MYCN in neuroblastoma.

Authors:  Lindi Chen; Nunzio Iraci; Samuele Gherardi; Laura D Gamble; Katrina M Wood; Giovanni Perini; John Lunec; Deborah A Tweddle
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

6.  The feasibility of assessing branched-chain amino acid metabolism in cellular models of prostate cancer with hyperpolarized [1-(13)C]-ketoisocaproate.

Authors:  Kelvin L Billingsley; Jae Mo Park; Sonal Josan; Ralph Hurd; Dirk Mayer; Eleanor Spielman-Sun; Dwight G Nishimura; James D Brooks; Daniel Spielman
Journal:  Magn Reson Imaging       Date:  2014-04-28       Impact factor: 2.546

7.  Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis.

Authors:  Judith M de Bont; Johan M Kros; Monique M C J Passier; Roel E Reddingius; Peter A E Sillevis Smitt; Theo M Luider; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-06-24       Impact factor: 12.300

8.  Diagnostic impact of ornithine decarboxylase in meningiomas.

Authors:  Werner Stenzel; Gabriele Röhn; Hrvoje Miletic; Herbert Radner; Martina Deckert; Ralf-Ingo Ernestus
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

9.  Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma.

Authors:  Andy J Cheng; Ngan Ching Cheng; Jette Ford; Janice Smith; Jayne E Murray; Claudia Flemming; Maria Lastowska; Michael S Jackson; Christopher S Hackett; William A Weiss; Glenn M Marshall; Ursula R Kees; Murray D Norris; Michelle Haber
Journal:  Eur J Cancer       Date:  2007-04-20       Impact factor: 9.162

10.  Mice with the CHEK2*1100delC SNP are predisposed to cancer with a strong gender bias.

Authors:  El Mustapha Bahassi; Susan B Robbins; Moying Yin; Gregory P Boivin; Raoul Kuiper; Harry van Steeg; Peter J Stambrook
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.